Analyst Ratings for Momenta Pharmaceuticals (MNTA)
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
N/A
Rating Score: 3.8 / 10
Percentile Rank: 40%
Rating Score: 3.8 / 10
Percentile Rank: 40%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/25/2020 | H.C. Wainwright | Douglas Tsao | Downgrade | Neutral (Buy) |
N/A (N/A) |
52.15 (52.48) |
0.63% | Details |
| 8/25/2020 | Raymond James | Danielle Brill | New Coverage | Market Perform (N/A) |
N/A (N/A) |
52.32 (52.48) |
0.31% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
